Speaker illustration

Doctor Nicholas Adamstein

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

Member of:

European Society of Cardiology

Dr. Nicholas Adamstein received his medical doctorate from Columbia University Vagelos College of Physicians and Surgeons in April, 2020. He began his internal medicine residency at Brigham and Women's Hospital in June, 2020. He will apply for fellowship in cardiology this year. His current research pertains to biomarkers for assessing residual inflammatory risk for atherosclerotic cardiovascular disease, assessing response to inflammatory pharmacotherapy, and gaining a better understanding of the pro-atherogenic inflammatory pathways. He has worked in the Brigham and Women's Hospital Center for Cardiovascular Disease Prevention in the Division of Preventive Medicine under the mentorship of Dr. Paul M Ridker since 2019. Dr. Adamstein has prior research experience in virology and tumor immunology. His hobbies include drawing, painting, and cooking.

The effect of ziltivekimab on the neutrophil-lymphocyte ratio: analysis from RESCUE

Event: ESC Congress 2022

Topic: Biomarkers

Session: Cardiovascular risk assessment - Biomarkers 2


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb